Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Docosahexaenoic Acid (DHA) Supplementation During Pregnancy Reduces the Risk of Preterm Birth in Threatened Preterm Labor

NCT06302023 is registered in ClinicalTrials.gov with Khon Kaen University as lead sponsor.

NCT NCT06302023
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06302023 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Docosahexaenoic Acid (DHA) Supplementation During Pregnancy Reduces the Risk of Preterm Birth in Threatened Preterm Labor
Lead sponsor
Khon Kaen University
Phase
Phase 2
Overall status
Completed
Start date
April 1, 2024
Completion date
October 7, 2024
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pregnant women diagnosed with threatened preterm labor